Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2004 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Trial of Deferiprone in Parkinson's Disease.
N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254.
N Engl J Med. 2022.
PMID: 36449420
Clinical Trial.
Site-directed mutagenesis and chemical modification of the two cysteine residues of the UDP-N-acetylmuramoyl:L-alanine ligase of Escherichia coli.
Nosal F, Masson A, Legrand R, Blanot D, Schoot B, van Heijenoort J, Parquet C.
Nosal F, et al.
FEBS Lett. 1998 Apr 24;426(3):309-13. doi: 10.1016/s0014-5793(98)00364-0.
FEBS Lett. 1998.
PMID: 9600257
Free article.
Item in Clipboard
Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C, Nosal F, Nardeux PC, Gallet X, Guymarho J, Baychelier F, Sempé P, Tovey MG, Escary JL, Eid P.
Cajean-Feroldi C, et al. Among authors: nosal f.
Biochemistry. 2004 Oct 5;43(39):12498-512. doi: 10.1021/bi049111r.
Biochemistry. 2004.
PMID: 15449939
Item in Clipboard
Cite
Cite